Marsh McLennan (MRSH) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
20 Oct, 2025Executive summary
Achieved 11% GAAP revenue growth and 4% underlying revenue growth in Q3 2025, with consolidated revenue at $6.4 billion and net income attributable to shareholders of $747 million.
Adjusted operating income rose 13% to $1.4 billion, and adjusted EPS increased 11% to $1.85; GAAP EPS was $1.51.
For the nine months ended September 30, 2025, revenue was $20.4 billion, net income $3.3 billion, and adjusted EPS $7.63.
Announced rebranding to Marsh, effective January, and launched the Thrive program targeting $400 million in savings over three years with $500 million in restructuring charges.
2024 marked the largest acquisition year, highlighted by the McGriff acquisition, and the launch of the Business and Client Services (BCS) unit.
Financial highlights
Q3 consolidated revenue was $6.4 billion, up 11% year-over-year; nine-month revenue reached $20.4 billion, up 11%.
Adjusted operating income for Q3 was $1.4 billion (+13%), with an adjusted operating margin of 22.7%.
Adjusted EPS for Q3 was $1.85 (+11%); GAAP EPS was $1.51.
Free cash flow margin stood at 16% in 2024, with $4 billion in free cash flow generated.
Repurchased $400 million of stock in Q3; $1 billion YTD.
Outlook and guidance
Expect mid-single-digit underlying revenue growth, solid adjusted EPS growth, and continued margin expansion for 2025.
Thrive program to deliver $400 million in savings over three years, with $500 million in restructuring costs.
Anticipate adjusted effective tax rate of 25–26% in 2025, excluding discrete items.
Plan to deploy ~$4.5 billion of capital in 2025 across dividends, acquisitions, and share repurchases.
Latest events from Marsh McLennan
- 2025 revenue up 10%, adjusted EPS up 9%, and $2.0B in share repurchases.MRSH
Q4 202527 Feb 2026 - Q2 revenue up 6%, EPS up 10%, margin 29%, and dividend raised 15% amid robust growth.MRSH
Q2 20243 Feb 2026 - Q3 revenue up 6%, strong segment growth, and $7.75B McGriff acquisition announced.MRSH
Q3 202419 Jan 2026 - Strong 2024 growth, record acquisitions, and margin expansion set up a positive 2025 outlook.MRSH
Q4 20249 Jan 2026 - Q1 2025 revenue up 9%, adjusted EPS up 5%, with strong segment growth and capital returns.MRSH
Q1 202519 Dec 2025 - Strong 2024 results, robust governance, and key votes on directors, pay, auditor, and equity plan.MRSH
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and incentive plan, all board-backed.MRSH
Proxy Filing1 Dec 2025 - Q2 2025 delivered 12% revenue growth, 11% EPS gain, and a 10% dividend increase.MRSH
Q2 20255 Nov 2025